It belongs to a novel class of agents known as triple agonists, designed to target three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
A part of Watch Medier Senior Safety Manager Clinical Supply Manager Global Clinical Lead, Clinical Development, Migraine & Pain Director, Drug Safety Operations Medical Writer responsible for Clinical Disclosure Pharmacokineticist, PK/PD Modelling & Simulation You need to be a subscriber to read the rest of the article
PlexusDx's Precision Peptide Genetic Test identifies key variants such as GLP1R rs6923761 and GIPR rs1800437 that influence how your body responds to GLP-1 medications
The pharmaceutical industry offers folic acid for therapeutic and prophylactic use
GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease
Because these pathways are deeply intertwined with reproductive hormones, ovulation, endometrial health, and chronic pelvic inflammation, researchers have started examining how GLP-1 drugs influence fertility, PCOS, menstrual health, and endometrial disorders
